Researchers investigated the relationship between COVID-19 health outcomes, economic hardship during the pandemic, and pre-pandemic socioeconomic status in United States families.
Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC?
Maintenance therapy with cetuximab (Erbitux) after FOLFIRI (leucovorin, fluorouracil, and irinotecan) plus cetuximab induction therapy led to better outcomes for patients with RAS wild-type metastatic